Specification :

Descriptions:
Biodegradable Polymer Coating Proven Safety and Efficacy Profile
* This DES uses a biodegradable polymer coating on the stainless steel stent platform. The proprietary, top-quality coating process allows the integrity of coated polymer after excessive stent expansion and a systemic elution of sirolimus in a well -controlled fashion after the stent implantation. The safety and efficacy of the product is well documented from a related randomized trial in Europe in CTO patients showing low re-stenosis rate and very promising late loss data.
Specifications:
Stent Plaform 316L Stainless Steel
Coating Material PLGA ( Biodegradable)
Coating Thickness 4.0± 1.0¼ m
Drug Sirolimus ( Rapamycine)
Drug Content 170¼ g/ cm2± 20¼ g/ cm2 ( 12mm, 18mm)
150¼ g/ cm2± 20¼ g/ cm2 ( 23mm, 28mm, 33mm)
Degradation Time > 2Months
Clinical Results in 90 Patients with CTO:
Control Group Rapa BMS
6 Month MACE 0% 0%
6 Month TVR 11% 55%
6 Month TLR 4% 19%
6 Month In-Stent Restenosis 16% 61%
6 Month In-Stent Late loss 0.41mm 1.46mm

Available Sizes:

Length 9 12 16 18 20 23 28 33
Diameter
2.50     
2.75      
3.00        
3.50        
4.00